Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 1

Interventions

Cyclophosphamide 3sodium-iodide symporter 1ruxolitinib 1fludarabine phosphate 1fludarabine 1cemiplimab 1X-Rays 1Whole-Body Irradiation 1Vorinostat 1Tacrolimus 1Specimen Handling 1Sirolimus 1Photons 1Peripheral Blood Stem Cell Transplantation 1Particle Accelerators 1Nivolumab 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Immunoglobulin G 1Etoposide 1Disulfides 1Cyclosporine 1CTLA-4 Antigen 1Busulfan 1Biopsy 1A-dmDT390-bisFv(UCHT1) protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell, Cutaneous × Particle Accelerators × 30 days × Clear all
NCT07608549 2026-05-27

FLASH Pilot Phase 1 Safety Study

Dartmouth-Hitchcock Medical Center

Phase NA Not yet recruiting
10 enrolled
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡